Long-Term Change in Cholesterol in Relation to Inflammation-Sensitive Plasma Proteins: A Longitudinal Study

Annals of Epidemiology

Volumn 17, Issue 1, 2007, Pages 57-63

  Engström, Gunnar ^a   Hedblad, Bo ^a   Janzon, Lars ^a   Lindgärde, Folke ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Cardiovascular; Cholesterol; Epidemiology; Inflammation

Indexed keywords

ALPHA 1 ANTITRYPSIN; CERULOPLASMIN; CHOLESTEROL; FIBRINOGEN; HAPTOGLOBIN; OROSOMUCOID; PLASMA PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

ACUTE-PHASE PROTEINS; ADULT; ALPHA 1-ANTITRYPSIN; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CERULOPLASMIN; CHOLESTEROL; FIBRINOGEN; HAPTOGLOBINS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; INFLAMMATION; LONGITUDINAL STUDIES; MALE; MASS SCREENING; MIDDLE AGED; OROSOMUCOID; RISK FACTORS; TRIGLYCERIDES;

EID: 33845402342     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2006.03.005     Document Type: Article

References (38)

1. Engström G., Lind P., Hedblad B., Stavenow L., Janzon L., and Lindgärde F. The effects of cholesterol and inflammation-sensitive proteins on incidence of stroke and myocardial infarction. Circulation 105 (2002) 2632-2637
2. Koenig W. Fibrin(ogen) in cardiovascular disease: An update. Thromb Haemost 89 (2003) 601-609
3. Frohlich M., Imhof A., Berg G., Hutchinson W.L., Pepys M.B., Boeing H., et al. Association between C-reactive protein and features of the metabolic syndrome: A population-based study. Diabetes Care 23 (2000) 1835-1839
4. Ross R. Atherosclerosis-An inflammatory disease. N Engl J Med 340 (1999) 115-126
5. Manolio T.A., Cushman M., Gottdiener J.S., Dobs A., Kuller L.H., Kronmal R.A., et al. Predictors of falling cholesterol levels in older adults: The Cardiovascular Health Study. Ann Epidemiol 14 (2004) 325-331
6. Erlinger T.P., Miller III E.R., Charleston J., and Appel L.J. Inflammation modifies the effects of a reduced-fat low-cholesterol diet on lipids: Results from the DASH-sodium trial. Circulation 108 (2003) 150-154
7. Moshage H. Cytokines and the hepatic acute phase response. J Pathol 181 (1997) 257-266
8. Khovidhunkit W., Kim M.S., Memon R.A., Shigenaga J.K., Moser A.H., Feingold K.R., et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: Mechanisms and consequences to the host. J Lipid Res 45 (2004) 1169-1196
9. Esteve E., Ricart W., and Fernandez-Real J.M. Dyslipidemia and inflammation: An evolutionary conserved mechanism. Clin Nutr 24 (2005) 16-31
10. Skretting G., Gjernes E., and Prydz H. Regulation of lecithin:cholesterol acyltransferase by TGF-beta and interleukin-6. Biochim Biophys Acta 1255 (1995) 267-272
11. Feister H.A., Auerbach B.J., Cole L.A., Krause B.R., and Karathanasis S.K. Identification of an IL-6 response element in the human LCAT promoter. J Lipid Res 43 (2002) 960-970
12. Greenberg A.S., Nordan R.P., McIntosh J., Calvo J.C., Scow R.O., and Jablons D. Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: A possible role for interleukin 6 in cancer cachexia. Cancer Res 52 (1992) 4113-4116
13. Hardardottir I., Moser A.H., Fuller J., Fielding C., Feingold K., and Grunfeld C. Endotoxin and cytokines decrease serum levels and extra hepatic protein and mRNA levels of cholesteryl ester transfer protein in Syrian hamsters. J Clin Invest 97 (1996) 2585-2592
14. Feingold K.R., Hardardottir I., and Grunfeld C. Beneficial effects of cytokine induced hyperlipidemia. Z Ernahrungswiss 37 Suppl 1 (1998) S66-S74
15. Broedl U.C., Jin W., and Rader D.J. Endothelial lipase: A modulator of lipoprotein metabolism upregulated by inflammation. Trends Cardiovasc Med 14 (2004) 202-206
16. Metzger S., Hassin T., Barash V., Pappo O., and Chajek-Shaul T. Reduced body fat and increased hepatic lipid synthesis in mice bearing interleukin-6-secreting tumor. Am J Physiol Endocrinol Metab 281 (2001) E957-E965
17. Berglund G., Eriksson K.F., Israelsson B., Kjellström T., Lindgärde F., Mattiasson I., et al. Cardiovascular risk groups and mortality in an urban Swedish male population: The Malmö Preventive Project. J Intern Med 239 (1996) 489-497
18. Treatment of hyperlipidemia [In Swedish]. Information from the medical products agency in Sweden. 1995;3:178-187.
19. European Atherosclerosis Society. Strategies for the prevention of coronary heart disease. A policy statement of the European Atherosclerosis Society. Eur Heart J 8 (1987) 77-88
20. Engström G., Stavenow L., Hedblad B., Lind P., Eriksson K.F., Janzon L., et al. Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: A population-based study. Diabetes 52 (2003) 442-447
21. Kristenson H., and Trell E. Indicators of alcohol consumption: Comparisons between a questionnaire (Mm-MAST), interviews and serum gamma-glutamyl transferase (GGT) in a health survey of middle-aged males. Br J Addict 77 (1982) 297-304
22. Engström G., Hedblad B., Rosvall M., Janzon L., and Lindgärde F. Occupation, marital status, and low-grade inflammation: Mutual confounding or independent cardiovascular risk factors?. Arterioscler Thromb Vasc Biol 26 (2006) 643-648
23. Laurell C.B. Electroimmuno assay. Scand J Clin Lab Invest Suppl 124 (1972) S21-S37
24. Lind P., Hedblad B., Stavenow L., Janzon L., Eriksson K.F., and Lindgärde F. Influence of plasma fibrinogen levels on the incidence of myocardial infarction and death is modified by other inflammation-sensitive proteins: A long-term cohort study. Arterioscler Thromb Vasc Biol 21 (2001) 452-458
25. Roschlau P., Bernt E., and Gruber W. Enzymatische bestimmung des gesamt-cholesterins in serum. [in German]. Z Klin Chem Klin Biochem 12 (1974) 403-407
26. Fernandez-Real J.M., Broch M., Vendrell J., Richart C., and Ricart W. Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. J Clin Endocrinol Metab 85 (2000) 1334-1339
27. Janciauskiene S., al Rayyes O., Floren C.H., and Eriksson S. Low density lipoprotein catabolism is enhanced by the cleaved form of alpha-1-antitrypsin. Scand J Clin Lab Invest 57 (1997) 325-335
28. Balestrieri M., Cigliano L., Simone M.L., Dale B., and Abrescia P. Haptoglobin inhibits lecithin-cholesterol acyltransferase in human ovarian follicular fluid. Mol Reprod Dev 59 (2001) 186-191
29. Ehrenwald E., Chisolm G.M., and Fox P.L. Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J Clin Invest 93 (1994) 1493-1501
30. Wierzbicki A.S., Poston R., and Ferro A. The lipid and non-lipid effects of statins. Pharmacol Ther 99 (2003) 95-112
31. Sidhu J.S., Cowan D., and Kaski J.C. The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients. J Am Coll Cardiol 42 (2003) 1757-1763
32. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 (1997) 973-979
33. Engström G., Lind P., Hedblad B., Berglund G., Stavenow L., Janzon L., et al. Blood pressure increase and incidence of hypertension in relation to inflammation-sensitive proteins. Arterioscler Thromb Vasc Biol 22 (2002) 2054-2058
34. Engström G., Hedblad B., Eriksson K.F., Janzon L., and Lindgärde F. Complement C3 is a risk factor for the development of diabetes. A population-based cohort study. Diabetes 54 (2005) 570-575
35. Engström G., Hedblad B., Stavenow L., Lind P., Janzon L., and Lindgärde F. Inflammations-sensitive plasma proteins are associated with future weight gain. Diabetes 52 (2003) 2097-2101
36. Baer D.J., Judd J.T., Clevidence B.A., and Tracy R.P. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: A randomized crossover study. Am J Clin Nutr 79 (2004) 969-973
37. Liu S., Manson J.E., Buring J.E., Stampfer M.J., Willett W.C., and Ridker P.M. Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr 75 (2002) 492-498
38. Fredrikson G.N., Hedblad B., Nilsson J.A., Alm R., Berglund G., and Nilsson J. Association between diet, lifestyle, metabolic cardiovascular risk factors, and plasma C-reactive protein levels. Metabolism 53 (2004) 1436-1442